会員専用ページ
ログイン
おすすめ商品
未掲載商品のお問い合わせ
プロメシアン 電子黒板
売れ筋商品
価格インフォメーション
なりすましメールについて

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 10 ed

出版済み 3-5週間でお届けいたします。

Title: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 10 ed
Subtitle: 2-Volume Set
Author: Blaser, Martin J., MD (Henry Rutgers Chair of the Human Microbiome, Professor of Medicine and Pathology & Laboratory Medicine - RWJMS; Director, Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA) / Cohen, Jeff
Publisher: Elsevier USA
ISBN: 9780323934992
Cover: Multiple-Component
Date: 2025年07月

DESCRIPTION
Offering more in-depth coverage of epidemiology, etiology, pathology, microbiology, immunology, and treatment of infectious agents than any other infectious disease resource, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 10th Edition, remains your #1 choice for authoritative, comprehensive information in this challenging field. Meticulously updated by a new editorial team led by Drs. Martin J. Blaser, Jeffrey I. Cohen, and Steven M. Holland, this two-volume masterwork brings together the knowledge and expertise of more than 650 contributing authors who are outstanding scholars and experts in their fields. For ID specialists and general practitioners alike, PPID provides a balanced, detailed perspective for any patient you encounter with a complex or difficult-to-treat infectious disease. Encyclopedic in its depth, contents, and referencing, PPID-10 is the one infectious disease book that needs to be on every practitioner’s shelf and in every medical library.

TABLE OF CONTENTS
Volume 1

I Basic Principles in the Diagnosis and Management of Infectious Diseases
A Microbial Pathogenesis
1 A Molecular Perspective of Microbial Pathogenicity
2 The Human Microbiome
3 Prebiotics, Probiotics, and Synbiotics
B Host Defense Mechanisms
4 Innate (General or Nonspecific) Host Defense Mechanisms
5 Adaptive Immunity: Antibodies and Immunodeficiencies
6 Cell-Mediated Defense Against Infection
7 Mucosal Immunity
8 Granulocytic Phagocytes
9 Complement and Deficiencies
10 Human Genetics and Infection
11 Nutrition, Immunity, and Infection
12 Evaluation of the Patient With Suspected Immunodeficiency
C Epidemiology of Infectious Disease
13 Principles of Applied Epidemiology for the Practice of Infectious Diseases
14 Emerging and Reemerging Infectious Disease Threats
15 Bioterrorism: An Overview
D Clinical Microbiology
16 The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation
E Anti-infective Therapy
17 Principles of Anti-infective Therapy
18 Molecular Mechanisms of Antibiotic Resistance in Bacteria
19 Pharmacokinetics and Pharmacodynamics of Anti-infective Agents
20 Penicillins and β-Lactamase Inhibitors
21 Cephalosporins and Cephalosporin/ β-Lactamase Inhibitor Combinations
22 Carbapenems, Carbapenem/ β-Lactamase Inhibitor Combinations, and Aztreonam
23 Antibiotic Allergy
24 Aminoglycosides
25 Tetracyclines, Tetracycline Derivatives, and Chloramphenicol
26 Rifamycins
27 Metronidazole
28 Macrolides and Clindamycin
29 Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
30 Streptogramins (Quinupristin-Dalfopristin) and Lipopeptides (Daptomycin)
31 Polymyxins (Polymyxin B and Colistin)
32 Linezolid, Tedizolid, and Other Oxazolidinones
33 Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
34 Quinolones
35 Antibiotics in Advanced Development and Other Agents
36 Urinary Tract Agents: Nitrofurantoin, Fosfomycin, and Methenamine
37 Topical Antibacterials
38 Antimycobacterial Agents
39 Bacteriophage Therapy, Endolysin Therapy, and Antimicrobial Peptide Therapy
40 Antifungal Agents: Polyene Antifungals
41 Antifungal Drugs: Azole
42 Antifungal Drugs: Echinocandins and Other Beta-d-Glucan Inhibitors
43 Antifungal Drugs: Flucytosine
44 Antimalarial Drugs
45 Drugs for Protozoal Infections Other Than Malaria
46 Drugs for Helminths
47 Antiviral Agents: General Principles
48 Antiviral Drugs for Influenza and Other Respiratory Virus Infections Except for SARS-CoV-2
49 Antivirals Against Herpesviruses
50 Antiviral Drugs Against Hepatitis Viruses
51 Miscellaneous Antiviral Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir)
52 Immunomodulators
53 Hyperbaric Oxygen
54 Antibiotic Stewardship
55 Designing and Interpreting Clinical Studies in Infectious Diseases
56 Outpatient Parenteral Antimicrobial Therapy

II Major Clinical Syndromes
A Fever
57 Temperature Regulation and the Pathogenesis of Fever
58 Fever of Unknown Origin
59 The Acutely Ill Patient With Fever and Rash
B Upper Respiratory Tract Infections
60 The Common Cold
61 Pharyngitis
62 Acute Laryngitis
63 Otitis Externa, Otitis Media, and Mastoiditis
64 Sinusitis
65 Epiglottitis
66 Infections of the Oral Cavity, Neck, and Head
C Pleuropulmonary and Bronchial Infections
67 Acute Bronchitis
68 Acute Exacerbations of Chronic Obstructive Pulmonary Disease
69 Acute Pneumonia
70 Pleural Effusion and Empyema
71 Bacterial Lung Abscess
72 Chronic Pneumonia
73 Cystic Fibrosis
D Urinary Tract Infections
74 Urinary Tract Infections
E Sepsis
75 Sepsis and Septic Shock
F Intraabdominal Infections
76 Peritonitis and Intraperitoneal Abscesses
77 Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis)
78 Pancreatic Infection
79 Splenic Abscess
80 Appendicitis
81 Diverticulitis and Neutropenic Enterocolitis
G Cardiovascular Infections
82 Endocarditis and Intravascular Infections
83 Prosthetic Valve Endocarditis
84 Infections of Nonvalvular Cardiovascular Devices
85 Prevention of Infective Endocarditis
86 Myocarditis and Pericarditis
87 Mediastinitis
H Central Nervous System Infections
88 Approach to the Patient With Central Nervous System Infection
89 Acute Meningitis
90 Chronic Meningitis
91 Encephalitis
92 Brain Abscess
93 Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
94 Cerebrospinal Fluid Shunt and Drain Infections
I Skin and Soft Tissue Infections
95 Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections
96 Myositis and Myonecrosis
97 Lymphadenitis and Lymphangitis
J Gastrointestinal Infections and Food Poisoning
98 Syndromes of Enteric Infection
99 Esophagitis
100 Diarrhea With Little or No Fever
101 Acute Dysentery Syndromes (Diarrhea With Fever)
102 Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers
103 Foodborne Disease (Food Poisoning)
104 Tropical Sprue and Environmental Enteric Dysfunction
K Bone and Joint Infections
105 Infectious Arthritis of Native Joints
106 Osteomyelitis
107 Orthopedic Implant-Associated Infections
L Diseases of the Reproductive Organs and Sexually Transmitted Diseases
108 Anogenital Skin and Mucous Membrane Lesions
109 Urethritis
110 Vulvovaginitis and Cervicitis
111 Infections of the Female Pelvis
112 Prostatitis, Epididymitis, and Orchitis
M Eye Infections
113 Introduction to Eye Infections
114 Microbial Conjunctivitis
115 Microbial Keratitis
116 Endophthalmitis
117 Infectious Causes of Uveitis
118 Periocular Infections
N Hepatitis
119 Viral Hepatitis
O Acquired Immunodeficiency Syndrome
120 Human Immunodeficiency Viruses
121 Global Perspectives on Human Immunodeficiency Virus Infection and AIDS
122 Epidemiology and Prevention of AIDS and HIV Infection, Including Preexposure Prophylaxis and HIV Vaccine Development
123 Diagnosis of Human Immunodeficiency Virus Infection
124 The Immunology of HIV-1 Infection, Mechanisms of Viral Persistence, and Prospects for Cure
125 General Clinical Manifestations of Human Immunodeficiency Virus Infection
126 Pulmonary Manifestations of Human Immunodeficiency Virus Infection
127 Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of Human Immunodeficiency Virus Infection
128 Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections
129 Pediatric Human Immunodeficiency Virus Infection
130 Antiretroviral Therapy for Human Immunodeficiency Virus Infection
131 Management of Opportunistic Infections Associated With Human Immunodeficiency Virus Infection
P COVID-19
132 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virology
133 Global Perspective and Epidemiology of COVID-19
134 Immunology and Diagnosis of SARS-CoV-2 and COVID-19
135 Clinical Manifestations of COVID-19 in Adults and Children
136 Treatment and Prevention of SARS-CoV-2 (COVID-19)
Q Miscellaneous Syndromes
137 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

VOLUME 2

III Infectious Diseases and Their Etiologic Agents
A Viral Diseases
138 Biology of Viruses and Viral Diseases
139 Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox), Mpox, and Cowpox
140 Other Poxviruses That Infect Humans: Parapoxviruses (Including Orf Virus), Molluscum Contagiosum, and Yatapoxviruses
141 Introduction to Herpesviridae
142 Herpes Simplex Virus
143 Chickenpox and Herpes Zoster (Varicella-Zoster Virus)
144 Cytomegalovirus
145 Epstein-Barr Virus (Infectious Mononucleosis, EBV-Associated Malignant Diseases, and Other Diseases)
146 Human Herpesvirus Types 6 and 7 (Exanthem Subitum)
147 Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)
148 Herpes B Virus
149 Adenoviruses
150 Papillomaviruses
151 JC, BK, and Other Polyomaviruses: Progressive Multifocal Leukoencephalopathy, BK Nephropathy, and Merkel Cell Carcinoma
152 Hepatitis B Virus
153 Hepatitis D Virus
154 Human Parvoviruses, Including Parvovirus B19, Human Bocaviruses, and Adeno-Associated Viruses (AAVs)
155 Orthoreoviruses and Orbiviruses
156 Coltiviruses (Colorado Tick Fever Virus) and Seadornaviruses
157 Rotaviruses
158 Alphaviruses
159 Rubella Virus (German Measles)
160 Flaviviruses
161 Hepatitis C
162 Coronaviruses, Including SARS and MERS
163 Parainfluenza Viruses
164 Mumps Virus
165 Respiratory Syncytial Virus
166 Human Metapneumovirus
167 Measles Virus (Rubeola)
168 Zoonotic Paramyxoviruses: Nipah, Hendra, and Pararubulaviruses
169 Vesicular Stomatitis Virus and Related Vesiculoviruses (Chandipura Virus)
170 Rabies (Rhabdoviruses)
171 Marburg and Ebola Virus Diseases
172 Influenza Viruses, Including Avian and Swine Influenza
173 Bunyavirus Infections: Hantavirus Syndromes, La Crosse Encephalitis, Rift Valley Fever, Crimean-Congo Hemorrhagic Fever, and Others
174 Lymphocytic Choriomeningitis Virus, Lassa Virus, Lujo Virus, and Other Hemorrhagic Fever Viruses (Arenaviruses)
175 Human T-Lymphotropic Virus
176 Introduction to Human Enteroviruses and Parechoviruses
177 Poliovirus
178 Coxsackieviruses, Echoviruses, and Other Enteroviruses (EV-D68, EV-D70, EV-A71)
179 The Human Parechoviruses
180 Hepatitis A Virus
181 Rhinovirus
182 Noroviruses and Sapoviruses (Caliciviruses)
183 Astroviruses and Picobirnaviruses
184 Hepatitis E Virus
B Prion Diseases
185 Prions and Prion Diseases of the CNS (Transmissible Neurodegenerative Diseases)
C Chlamydial Diseases
186 Chlamydia trachomatis
187 Psittacosis (Due to Chlamydia psittaci)
188 Chlamydia pneumoniae
D Mycoplasma Diseases
189 Mycoplasmoides (Mycoplasma) pneumoniae
190 Genital Mycoplasmas (Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma Species)
E Rickettsioses, Ehrlichioses, and Anaplasmoses
191 Introduction to Rickettsioses, Ehrlichioses, and Anaplasmoses
192 Rickettsia rickettsii and Other Spotted Fever Group Rickettsiae
193 Coxiella burnetii (Q Fever)
194 Rickettsia prowazekii (Epidemic Typhus)
195 Rickettsia typhi (Murine Typhus)
196 Orientia tsutsugamushi (Scrub TYphus)
197 Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Other Anaplasmataceae
F Bacterial Diseases
198 Introduction to Bacteria and Bacterial Diseases
i. Infections Due to Gram-Positive Bacteria
199 Staphylococcus aureus
200 Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci
201 Classification of Streptococci
202 Streptococcus pyogenes (Group A Streptococcus)
203 Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis
204 Streptococcus pneumoniae
205 Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species
206 Streptococcus agalactiae (Group B Streptococci)
207 Viridans Streptococci, Nutritionally Variant Streptococci, and Groups C and G Streptococci
208 Streptococcus anginosus Group
209 Corynebacterium diphtheriae (Diphtheria)
210 Other Coryneform Bacteria and Rhodococci
211 Listeria monocytogenes
212 Bacillus anthracis (Anthrax)
213 Bacillus Species and Related Genera Other Than Bacillus anthracis
214 Erysipelothrix rhusiopathiae
215 Whipple Disease
ii. Infections Due to Gram-Negative Bacteria
216 Neisseria meningitidis
217 Neisseria gonorrhoeae (Gonorrhea)
218 Moraxella catarrhalis, Kingella, and Other Gram-Negative Cocci
219 Vibrio cholerae
220 Other Pathogenic Vibrios
221 Campylobacter jejuni and Related Species
222 Helicobacter pylori and Other Gastric Helicobacter Species
223 Enterobacterales (Enterobacteriaceae)
224 Pseudomonas aeruginosa and Other Pseudomonas Species
225 Stenotrophomonas maltophilia and Burkholderia cepacia Complex
226 Burkholderia pseudomallei and Burkholderia mallei (Melioidosis, Glanders)
227 Acinetobacter Species
228 Salmonella Species
229 Bacillary Dysentery: Shigella and Enteroinvasive Escherichia coli
230 Haemophilus Species, Including H. influenzae and H. ducreyi (Chancroid)
231 Brucellosis (Brucella Species)
232 Francisella tularensis (Tularemia)
233 Pasteurella Species
234 Plague (Yersinia pestis)
235 Yersinia enterocolitica and Yersinia pseudotuberculosis
236 Bordetella pertussis
237 Rat-Bite Fever: Streptobacillus moniliformis and Spirillum minus
238 Legionnaires’ Disease and Pontiac Fever
239 Capnocytophaga Species
240 Bartonella, Including Cat-Scratch Disease
241 Klebsiella granulomatis (Donovanosis, Granuloma Inguinale)
242 Other Gram-Negative and Gram-Variable Bacilli
iii. Infections Due to Spirochetal Bacteria
243 Syphilis (Treponema pallidum)
244 Endemic Treponematoses
245 Leptospira Species (Leptospirosis)
246 Relapsing Fever Caused by Borrelia Species
247 Lyme Disease (Lyme Borreliosis) Due to Borrelia burgdorferi
iv. Infections Due to Anaerobic Bacteria
248 Anaerobic Infections: General Concepts
249 Clostridioides (Clostridium) difficile Infection
250 Tetanus (Clostridium tetani)
251 Botulism (Clostridium botulinum)
252 Diseases Caused by Clostridium
253 Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli)
254 Anaerobic Cocci and Anaerobic Gram-Positive Nonsporulating Bacilli
v. Infections Due to Acid-Fast Organisms
255 Mycobacterium tuberculosis
256 Leprosy (Mycobacterium leprae)
257 Mycobacterium avium Complex
258 Infections Caused by Nontuberculous Mycobacteria Other Than Mycobacterium avium Complex
259 Nocardia Species
260 Agents of Actinomycosis
G Mycoses
261 Introduction to Mycoses
262 Candida Species
263 Aspergillus Species
264 Agents of Mucormycosis and Entomophthoramycosis
265 Sporothrix schenckii
266 Chromoblastomycosis
267 Mycetoma
268 Cryptococcosis (Cryptococcus neoformans and Cryptococcus gattii)
269 Histoplasma capsulatum (Histoplasmosis)
270 Blastomyces
271 Coccidioides Species
272 Dermatophytosis (Ringworm) and Other Superficial Mycoses
273 Paracoccidioides
274 Uncommon Fungi and Related Species
275 Pneumocystis Species
276 Microsporidiosis
H Protozoal Diseases
277 Introduction to Protozoal Diseases
278 Entamoeba Species, Including Amebic Colitis and Liver Abscess
279 Free-Living Amebae
280 Malaria (Plasmodium Species)
281 Leishmania Species: Visceral, Cutaneous, and Mucosal Leishmaniasis
282 Trypanosoma Species (American Trypanosomiasis, Chagas Disease)
283 Agents of African Trypanosomiasis (Sleeping Sickness)
284 Toxoplasma gondii
285 Giardia lamblia
286 Trichomonas vaginalis
287 Babesia Species
288 Cryptosporidiosis (Cryptosporidium Species)
289 Cyclospora cayetanensis, Cystoisospora belli, Sarcocystis Species, Balantidium coli, and Blastocystis Species
I Diseases Due to Toxic Algae
290 Human Illness Associated With Cyanobacteria and Harmful Algal Blooms, Including Fish and Shellfish Poisoning Syndromes
J Diseases Due to Helminths
291 Introduction to Helminth Infections
292 Intestinal Nematodes (Roundworms)
293 Tissue Nematodes, Including Trichinellosis, Dracunculiasis, and the Filariases
294 Trematodes (Schistosomes and Liver, Intestinal, and Lung Flukes)
295 Tapeworms (Cestodes)
296 Visceral Larva Migrans and Other Uncommon Helminth Infections
K Ectoparasitic Diseases
297 Introduction to Ectoparasitic Diseases
298 Lice (Pediculosis)
299 Scabies
300 Myiasis and Tungiasis
301 Mites, Including Chiggers
302 Ticks, Including Tick Paralysis
L Diseases of Unknown Etiology
303 Kawasaki Disease

IV. Special Problems
A Nosocomial Infections
304 Infection Prevention and Control in Healthcare
305 Disinfection, Sterilization, and Hospital Waste
306 Infections Caused by Percutaneous Intravascular Devices
307 Nosocomial Pneumonia
308 Catheter-Associated Urinary Tract Infection (CAUTI) and CA-AB
309 Transfusion- and Transplant-Transmitted Infections
B Infections in Special Hosts
310 Infections in the Immunocompromised Host: Principles
311 Prophylaxis and Empirical Therapy in Cancer Patients
312 Infections in Hematopoietic Cell Transplantation
313 Infections in Solid Organ Transplant Recipients
314 Infections in Older Adults
315 Infections in Asplenic Patients
316 Infections in Persons Who Inject Drugs
C Surgical- and Trauma-Related Infections
317 Surgical Site Infections and Prophylaxis
318 Burns
319 Infections Following Trauma
320 Bites
D Immunization
321 Principles of Immunization for Public Health
322 Immunizations for Specific Infections
323 Protection of Travelers
324 Infections in Returning Travelers
E Emerging Issues in Infectious Diseases
325 Zoonoses
326 Communicating About Infectious Diseases to the Public
327 Basic Principles in Climate Change and Infectious Diseases
Amazon Pay
当サイトでは、「Amazon.co.jp」アカウントに登録されているクレジットカード情報や配送先情報などを利用してご購入いただける「Amazon Pay」をご利用いただけます。
「Amazon.co.jp」アカウントに登録された配送先とクレジットカード情報は安全に保管されています。クレジットカード情報が当社に開示・保存されることはありません。
Amazonのセキュリティ基準に基づいて安全に決済が行われます。

ご注文確定時に一括での決済となります。
※1回のご注文で複数冊ご注文された場合、入荷状況によっては分割納品が発生する場合がございます。
請求書払い(法人のお客様)
法人のお客様は請求書払い(後払い)でのご注文を承ります。
初回ご注文時に弊社規定の与信審査を行わせていただく場合がございます。

納品の際に見積書、納品書、請求書を同封致しますので、弊社の取引銀行口座にご入金下さい。
弊社の取引銀行口座番号は、請求書に記載されています。

誠に恐れ入りますが、振込手数料はお客様のご負担とさせていただきます。

配送先情報の「備考欄」に請求書の宛名、必要な書類と枚数、書類作成に関するご要望などをご入力ください。

商品の送付先は原則としてお客様のご所属先法人宛とさせていただきます。
クレジットカード決済
発送の準備ができましたら、ご指定のカードより決済させていただきます。

クレジットカードの決済につきましては、GMOイプシロン株式会社の「イプシロン決済サービス」を利用しています。
高度なセキュリティシステムにより、安全に決済をご利用いただけます。

※1回のご注文で複数冊ご注文された場合、入荷状況によっては分割納品が発生する場合がございます。
このような場合のクレジットカードの決済につきましては、完納時に一括決済をさせていただきます。
※不正利用防止の為、ご注文者様名と同じ名義のクレジットカードにて決済をおこなってください。
※ご注文情報等に不備や不審な点がある場合はご注文者様の本人確認(電話確認等)をお願いする場合がございます。また、不正利用を防止するためにご注文をキャンセルさせていただく場合がございます。
ゆうメール、ゆうパックまたは宅配便
【配送方法】
ご注文時にご指定頂いたお届け先に弊社指定のゆうメール、一般小包郵便物(ゆうパック)、または宅配便にてお送り致します。また、営業担当員が直接お届けすることもございます。
【送料】
送料は全国一律 500円となります。
ただし、1回のご注文金額の合計が4,500円(税込)以上の場合は、送料無料となります。
【海外発送】
弊社では海外発送は承っておりません。
We don’t ship overseas.
販売業者 株式会社ニュートリノ東京  会社概要
運営統括責任者名 代表取締役社長 小黒 総一郎
郵便番号 1820024
住所 東京都調布市布田1-44-3 高橋ビル
商品代金以外の料金の説明 販売価格とは別に配送料、振込手数料がかかる場合もございます。
申込有効期限 <ニュートリノ商品購入確認メール(自動配信)>を弊社にて送信以降、原則としてキャンセルはお受けしておりません。
また、弊社よりお申込みをキャンセルすることはございませんが、出版状況や在庫などは常に変動しており、状況によってはキャンセルさせていただくことがございます。
不良品 注文とは異なる商品が届いた場合や乱丁、落丁のみ返品・交換を承ります。その際は、到着から7日以内にメール、電話、ファックスにてご連絡願います。また、その他のお客様のご都合による商品の返品・交換はお受けできません。
販売数量 各商品ページにてご確認ください。
引渡し時期 ご注文商品は原則として海外の出版社からのお取り寄せとなります。既刊本につきましては3〜5週間、未刊本につきましては刊行後2〜3週間程となります。一時品切れ、入荷の遅延、出版の遅延などでご注文商品の納期に遅れが見込まれる場合は、ご登録のメールアドレスにお知らせのメールをお送り致します。
お支払い方法 請求書払い(法人のお客様)
クレジットカード
Amazon Pay

お支払い期限 請求書払い(法人のお客様)によるご注文について
納品の際に見積書、納品書、請求書を同封致しますので、銀行または郵便局の弊社の口座にご送金ください。
※銀行または郵便局の弊社口座番号は、請求書に記載されています。

ご注文ページの備考欄にて、請求書の宛名、必要書類の枚数、書類作成に関するご要望などをご入力ください。
返品期限 (返品特約) 弊社からの<ニュートリノ商品購入確認メール(自動配信)>送信直後のキャンセル以外は承っておりません。

注文とは異なる商品が届いた場合や乱丁、落丁のみ返品・交換を承ります。その際は、到着から7日以内にメール、電話、ファックスにてご連絡願います。また、その他のお客様のご都合による商品の返品・交換はお受けできません。
返品送料 注文とは異なる商品が届いた場合や乱丁、落丁による返品・交換に該当する場合は当方で負担いたします。
資格・免許 全省庁統一資格業者コード : 0000192808
適格請求書発行事業者登録番号:T4012401035495
屋号またはサービス名 ニュートリノ東京 ECサイト
電話番号 042-484-5550 Non Japanese speaker - Please E-mail: E-mail(In English Only)
公開メールアドレス info@neutrino.co.jp
ホームページアドレス https://neutrino.shop-pro.jp/